Medicines Law & Policy’s director, Ellen ’t Hoen, receives high Netherlands honour for her work on medicines access

Ellen ‘t Hoen has been appointed Officer of the Order of Oranje-Nassau, a royal award which recognises those who merit particular appreciation from society for the contributions they have made. The award was granted under the heading of Foreign Trade and Development Cooperation, and in particular for her dedication to achieving equitable access to affordable medicines worldwide.

“Because of her large and long-term contribution Ms ‘t Hoen has made to a better and more fair regulation of access to and affordability of medicines worldwide and her systematic commitment to vulnerable people in society” she was chosen for this award, said the official report.

“It is very special to receive the award right now in times of the Covid-19 pandemic that has laid bare so many issues related to the equitable distribution of important health technologies,” said ‘t Hoen upon receiving the news.

UNITAID, with whom ‘t Hoen has worked closely for many years – including on the creation of the Medicines Patent Pool – also released a statement congratulating her on this achievement.

Avatar photo
+ posts

Kaitlin Mara, MSc, has been writing about international intellectual property and innovation policy for over 15 years.

Newsletter

Never miss a post! Sign up for ML&P's newsletter.

Recent Articles

Medicines Law & Policy statement at WHO PABS negotiations (IGWG 5)

Co-chairs, Thank you for the opportunity to say a few words.  My comments address issues related to technology transfer (TT), a topic we have been...

Legal tools that lower medicines prices have expanded access to medicines for over two decades, research reveals

LONDON, UK: Millions of people are priced out of access to life-saving medicines. Use of legal tools to reduce prices has been under-reported and...

Wrapping up 2025: A tumultuous year for global public health law & policy

The end of 2025, a tumultuous year for global public health, is here, and it’s time for the usually highly biased Medicines Law &...

The Role of Activism in Shaping Law and Policies that Support Access to Medicines

This article is also available as a PDF here. Almost 26 years ago, here in Amsterdam, on November 25-26, 1999, Health Action International, Médecins Sans...

Generic versions of a lifesaving cystic fibrosis treatment will save patients $360,000 a year – expanding access and prolonging lives

Generic versions of a cystic fibrosis treatment will now be available at $6,375 per child, per year under a new scheme – offering hope...

Related Articles